Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros











Intervalo de ano de publicação
1.
Mem Inst Oswaldo Cruz ; 111(2): 93-100, 2016 Feb.
Artigo em Inglês | MEDLINE | ID: mdl-26841047

RESUMO

Developing a fast, inexpensive, and specific test that reflects the mutations present in Mycobacterium tuberculosis isolates according to geographic region is the main challenge for drug-resistant tuberculosis (TB) control. The objective of this study was to develop a molecular platform to make a rapid diagnosis of multidrug-resistant (MDR) and extensively drug-resistant TB based on single nucleotide polymorphism (SNP) mutations present in therpoB, katG, inhA,ahpC, and gyrA genes from Colombian M. tuberculosis isolates. The amplification and sequencing of each target gene was performed. Capture oligonucleotides, which were tested before being used with isolates to assess the performance, were designed for wild type and mutated codons, and the platform was standardised based on the reverse hybridisation principle. This method was tested on DNA samples extracted from clinical isolates from 160 Colombian patients who were previously phenotypically and genotypically characterised as having susceptible or MDR M. tuberculosis. For our method, the kappa index of the sequencing results was 0,966, 0,825, 0,766, 0,740, and 0,625 forrpoB, katG, inhA,ahpC, and gyrA, respectively. Sensitivity and specificity were ranked between 90-100% compared with those of phenotypic drug susceptibility testing. Our assay helps to pave the way for implementation locally and for specifically adapted methods that can simultaneously detect drug resistance mutations to first and second-line drugs within a few hours.


Assuntos
DNA Bacteriano/genética , Técnicas de Diagnóstico Molecular/métodos , Mutação/genética , Mycobacterium tuberculosis/isolamento & purificação , Polimorfismo de Nucleotídeo Único/genética , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Antibióticos Antituberculose/farmacologia , Colômbia , Tuberculose Extensivamente Resistente a Medicamentos/classificação , Tuberculose Extensivamente Resistente a Medicamentos/diagnóstico , Fluoroquinolonas/farmacologia , Amplificação de Genes , Humanos , Isoniazida/farmacologia , Mycobacterium tuberculosis/efeitos dos fármacos , Hibridização de Ácido Nucleico/métodos , Rifampina/farmacologia , Análise de Sequência de DNA , Tuberculose Resistente a Múltiplos Medicamentos/genética
2.
Mem. Inst. Oswaldo Cruz ; 111(2): 93-100, Feb. 2016. tab, graf
Artigo em Inglês | LILACS | ID: lil-772615

RESUMO

Developing a fast, inexpensive, and specific test that reflects the mutations present in Mycobacterium tuberculosis isolates according to geographic region is the main challenge for drug-resistant tuberculosis (TB) control. The objective of this study was to develop a molecular platform to make a rapid diagnosis of multidrug-resistant (MDR) and extensively drug-resistant TB based on single nucleotide polymorphism (SNP) mutations present in therpoB, katG, inhA,ahpC, and gyrA genes from Colombian M. tuberculosis isolates. The amplification and sequencing of each target gene was performed. Capture oligonucleotides, which were tested before being used with isolates to assess the performance, were designed for wild type and mutated codons, and the platform was standardised based on the reverse hybridisation principle. This method was tested on DNA samples extracted from clinical isolates from 160 Colombian patients who were previously phenotypically and genotypically characterised as having susceptible or MDR M. tuberculosis. For our method, the kappa index of the sequencing results was 0,966, 0,825, 0,766, 0,740, and 0,625 forrpoB, katG, inhA,ahpC, and gyrA, respectively. Sensitivity and specificity were ranked between 90-100% compared with those of phenotypic drug susceptibility testing. Our assay helps to pave the way for implementation locally and for specifically adapted methods that can simultaneously detect drug resistance mutations to first and second-line drugs within a few hours.


Assuntos
Humanos , DNA Bacteriano/genética , Técnicas de Diagnóstico Molecular/métodos , Mutação/genética , Mycobacterium tuberculosis/isolamento & purificação , Polimorfismo de Nucleotídeo Único/genética , Tuberculose Resistente a Múltiplos Medicamentos/diagnóstico , Antibióticos Antituberculose/farmacologia , Colômbia , Tuberculose Extensivamente Resistente a Medicamentos/classificação , Tuberculose Extensivamente Resistente a Medicamentos/diagnóstico , Fluoroquinolonas/farmacologia , Amplificação de Genes , Isoniazida/farmacologia , Mycobacterium tuberculosis/efeitos dos fármacos , Hibridização de Ácido Nucleico/métodos , Rifampina/farmacologia , Análise de Sequência de DNA , Tuberculose Resistente a Múltiplos Medicamentos/genética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA